Figure 1: Repaglinide In Combination With Pioglitazone: Hba1c Values (Repaglinide Fig1)
Repaglinide Tablet
Product Images NDC 65862-672
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 65862-672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label-principal Display Panel (0.5 mg (100 Tablet Bottle))
This is a prescription drug information label for Repaglinide tablets, USP with a strength of 0.5mg. The label contains information on dosage, storage, handling, and dispensing of the medication. The drug is distributed by Aurobindo Pharma USA, Inc. from East Windsor, New Jersey.*
Package Label-principal Display Panel (1 mg (100 Tablet Bottle))
This is a medication called Repaglinide in the form of 1mg Tablets. The medication is distributed by Aurobindo Pharma USA, Inc. The usual dosage is available in the package insert. The medication should be stored at a temperature between 20° to 25°C and protected from moisture. It should be kept out of reach of children and dispensed in a tightly closed container with a child-resistant closure. There is no readable information available in the "Over printing Zone Coding Area."*
Package Label-principal Display Panel (2 mg (100 Tablet Bottle))
This is a prescription drug containing Repaglinide in tablet form. Each tablet contains 2mg of Repaglinide, and the bottle has 100 tablets. The usual dosage information can be found in the package insert. It should be stored at 20°C to 25°C, protected from moisture, kept in a tightly closed bottle, and away from reach of children. The distributor is Aurobindo Pharma USA, located at 279 Princeton East Windsor, NJ 08520. The label also shows the drug code number and the manufacturing location in India.*
Chemical Structure (Repaglinide Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
